Innovafeed has entered a new phase of development after successfully scaling its insect-based ingredient platform to industrial levels, backed by a €51 million funding round.
The French company, a leading producer of black soldier fly (Hermetia illucens) ingredients for animal feed, pet food and agriculture, said it has now completed the transition from research-led innovation to large-scale industrial production.
At the centre of this shift is its Nesle facility in northern France, which is now fully operational and repositioned as a hub for commercial growth rather than experimental development.
Production scale delivers cost and volume gains
Since its last funding round in 2022, Innovafeed has achieved what it describes as three key milestones:
- Industrial maturity: More than 15,000 tonnes of protein and oil produced at Nesle, with output increasing tenfold and production costs reduced by a factor of seven
- Commercial traction: Revenues doubling year-on-year, driven by partnerships across aquaculture and pet food
- Environmental performance: Products delivering a 70-90% reduction in carbon emissions compared with conventional ingredients
The company claims its scale is now three times larger than the world’s next-largest player, underlining the competitive advantage of early industrialisation in the insect protein sector.
Reorganisation sees 60 roles cut in R&D
As part of its transition, Innovafeed is undertaking a restructuring of its operations, including cutting around 60 positions, primarily within its zootechnical R&D activities.
Two-thirds of the reductions will affect the company’s historical site in Gouzeaucourt, with remaining activities consolidated into the Nesle facility.
The company said the move reflects the end of an intensive R&D and industrial development phase, with resources now being redirected toward commercial deployment and product optimisation.
Innovafeed added that the restructuring would be carried out with support for affected employees and in consultation with employee representatives and authorities.
€51m funding to drive commercial expansion
The new €51m funding round, supported by existing investors including Creadev, Temasek, ADM and Qatar Investment Authority, will be used to accelerate the next stage of growth.
Key priorities include scaling commercial deployment of its Hilucia™ ingredient range, investing in equipment and processes to develop new applications and optimising production capacity and efficiency at existing industrial assets
CEO and co-founder Clément Ray said the company is now focused on capturing value from the functional benefits of its ingredients, particularly in aquaculture and pet food.
Market validation builds momentum
Commercial partners are already scaling up use of insect-based ingredients.
NaturAlleva, an aquaculture player, said it is adopting Innovafeed’s products at scale following years of nutritional trials, while pet food manufacturers highlighted their role in hypoallergenic formulations and premium product growth.
This growing demand reflects a broader shift across feed and food systems toward alternative proteins that reduce dependence on marine resources such as fishmeal.
A shift from innovation to execution
Innovafeed’s transition mirrors a wider trend across agrifood tech, where companies are moving from proof-of-concept innovation to capital-intensive industrial scale-up and commercial execution.
While the restructuring, particularly the reduction in R&D roles, highlights the cost of that transition, the company is betting that its early investment in scale now positions it to lead a rapidly maturing market.
“With a fully operational large-scale production facility, Innovafeed has developed a world-unique industrial asset,” said Creadev’s food managing director Bénédicte Monpert.
As pressure mounts on global food systems to reduce environmental impact and dependency on finite resources, the company’s next challenge will be turning its industrial platform into sustained commercial leadership.
For Innovafeed, the message is clear: the scale-up phase is complete; now comes the race to market.
